Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.

Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.

Item
http://www.wikidata.org/entity/Q37520646
Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel diseaseAltered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.Sphingolipids: the nexus between Gaucher disease and insulin resistance.Quantitative metabolic profiling of lipid mediators.Gaucher disease and bone manifestations.Hepatoprotective effect of DT56a is associated with changes in natural killer T cells and regulatory T cells.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals.
P2860

Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent.

Item
http://www.wikidata.org/entity/Q37520646
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucocerebroside: an evolution ...... a new immunomodulatory agent.
@en
Glucocerebroside: an evolution ...... a new immunomodulatory agent.
@nl
type
label
Glucocerebroside: an evolution ...... a new immunomodulatory agent.
@en
Glucocerebroside: an evolution ...... a new immunomodulatory agent.
@nl
prefLabel
Glucocerebroside: an evolution ...... a new immunomodulatory agent.
@en
Glucocerebroside: an evolution ...... a new immunomodulatory agent.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Glucocerebroside: an evolution ...... a new immunomodulatory agent.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698